Cargando…
The Interleukin-17 Family of Cytokines in Breast Cancer
Breast cancer (BC) is the most common cancer in women worldwide and remains a major cause of mortality with an expected 137,000 death this year in Europe. Standard management of metastatic BC comprises hormonotherapy, chemotherapy, and targeted therapies. Cyclin dependent kinase (CDK) and mammalian...
Autores principales: | Fabre, Joseph Antoine Salvator, Giustiniani, Jérôme, Garbar, Christian, Merrouche, Yacine, Antonicelli, Frank, Bensussan, Armand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321268/ https://www.ncbi.nlm.nih.gov/pubmed/30518157 http://dx.doi.org/10.3390/ijms19123880 |
Ejemplares similares
-
Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type
por: Fabre, Joseph, et al.
Publicado: (2016) -
IL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cells
por: Merrouche, Yacine, et al.
Publicado: (2016) -
Chemotherapy treatment induces an increase of autophagy in the luminal breast cancer cell MCF7, but not in the triple-negative MDA-MB231
por: Garbar, Christian, et al.
Publicado: (2017) -
IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells
por: Mombelli, Sarah, et al.
Publicado: (2015) -
Triple-negative and HER2-overexpressing breast cancer cell sialylation impacts tumor microenvironment T-lymphocyte subset recruitment: a possible mechanism of tumor escape
por: Garbar, Christian, et al.
Publicado: (2018)